Seminars in Hematology
Volume 40, Issue 4 , Pages 274-280 , October 2003

Gene expression profiling in T-cell acute lymphoblastic leukemia

  • Adolfo A Ferrando

      Affiliations

    • Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
    • ,
  • A.Thomas Look

      Affiliations

    • Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationAddress correspondence to A. Thomas Look, MD, Department of Pediatric Oncology, Mayer-630, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA

References 

  1. Armstrong SA, Staunton JE, Silverman LB, et al.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2002;30:41–47
  2. Baer R, Hwang LY, Bash RO. Transcription factors of the bHLH and LIM families (Synergistic mediators of T cell acute leukemia?). Curr Top Microbiol Immunol. 1997;220:55–65
  3. Bash RO, Hall S, Timmons CF, et al.  Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A Pediatric Oncology Group study. Blood. 1995;86:666–676
  4. Bernard O, Guglielmi P, Jonveaux P, et al.  Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes. Cancer. 1990;1:194–208
  5. Bernard OA, Busson-LeConiat M, Ballerini P, et al.  A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the HOX11L2 gene in T acute lymphoblastic leukemia. Leukemia. 2001;15:1495–1504
  6. Chessells JM, Bailey C, Richards SM. Intensification of treatment and survival in all children with lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet. 1995;345:143–148
  7. Dear TN, Colledge WH, Carlton MB, et al.  The Hox11 gene is essential for cell survival during spleen development. Development. 1995;121:2909–2915
  8. Dube ID, Kamel-Reid S, Yuan CC, et al.  A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). Blood. 1991;78:2996–3003
  9. Ernst P, Wang J, Korsmeyer SJ. The role of MLL in hematopoiesis and leukemia. Curr Opin Hematol. 2002;9:282–287
  10. Ferrando AA, Look AT. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol. 2000;37:381–395
  11. Ferrando AA, Armstrong SA, Neuberg DS, et al.  Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias (Dominance of HOX dysregulation). Blood. 2003;102:262–268
  12. Ferrando AA, Neuberg DS, Staunton J, et al.  Gene expression signatures define novel oncogenic pathways in T-cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75–87
  13. Finger LR, Kagan J, Christopher G, et al.  Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA. 1989;86:5039–5043
  14. Hansen-Hagge TE, Schafer M, Kiyoi H, et al.  Disruption of the RanBP17/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11). Leukemia. 2002;16:2205–2212
  15. Hatano M, Roberts CW, Minden M, et al.  Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science. 1991;253:79–82
  16. McGuire EA, Hockett RD, Pollock KM, et al.  The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol. 1989;9:2124–2132
  17. Mellentin JD, Smith SD, Cleary ML. LYL-l, A novel gene altered by chromosomal translocation in T-cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell. 1989;58:77–83
  18. Milne TA, Briggs SD, Brock HW, et al.  MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell. 2002;10:1107–1117
  19. Porcher C, Swat W, Rockwell K, et al.  The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 1996;86:47–57
  20. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;33:605–615
  21. Pullen J, Shuster JJ, Link M, Borowitz M, et al.  Significance of commonly used prognostic factors differs for children with T-cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL (A Pediatric Oncology Group (POG) study). Leukemia. 1999;13:1696–1707
  22. Rivera GK, Raimondi SC, Hancock ML, et al.  Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet. 1991;337:61–66
  23. Robb L, Elwood NJ, Elefanty AG, et al.  The SCL gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 1996;15:4123–4129
  24. Roberts CWM, Shutter JR, Korsmeyer SJ. Hox11 controls the genesis of the spleen. Nature. 1994;368:747–749
  25. Royer-Pokora B, Loos U, Ludwig WD. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene. 1991;6:1887–1893
  26. Schiffer CA, Larson RA, Bloomfield CD. Cancer and Leukemia Group B (CALGB) studies in adult acute lymhocytic leukemia. Leukemia. 1992;6(suppl 2):171–174
  27. Schrappe M, Reiter A, Ludwig WD, et al.  Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood. 2000;95:3310–3322
  28. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature. 1995;373:432–434
  29. Silverman LB, Gelber RD, Dalton VK, et al.  Improved outcome for children with acute lymphoblastic leukemia (Results of Dana-Farber Consortium Protocol 91–01). Blood. 2001;97:1211–1218
  30. Varas A, Hager-Theodorides AL, Sacedon R, et al.  The role of morphogens in T-cell development. Trends Immunol. 2003;24:197–206
  31. Wadman I, Li J, Bash RO, et al.  Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J. 1994;13:4831–4839
  32. Wang J, Jani-Sait SN, Escalon EA, et al.  The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc Natl Acad Sci USA. 2000;97:3497–3502
  33. Warren AJ, Colledge WH, Carlton MBL, et al.  The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell. 1994;78:45–57
  34. Xia Y, Brown L, Yang CY, et al.  TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. Proc Natl Acad Sci USA. 1991;88:11416–11420
  35. Yeoh EJ, Ross ME, Shurtleff SA, et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1:133–143
  36. Yu BD, Hess JL, Horning SE, et al.  Altered Hox expression and segmental identity in Mll-mutant mice. Nature. 1995;378:505–508

☆ Supported in part by National Institutes of Health Grants No. CA 59571 and CA 68484, and a center grant from the Leukemia and Lymphoma Society. A.A.F. is a Fellow of the Leukemia and Lymphoma Society.

PII: S0037-1963(03)00195-1

doi: 10.1016/S0037-1963(03)00195-1

Seminars in Hematology
Volume 40, Issue 4 , Pages 274-280 , October 2003

Article Tools

* Image Usage & Resolution